Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats

Transgenic Research

Volumn 5, Issue 6, 1996, Pages 443-450

  Charreau, Béatrice ^a   Tesson, Laurent ^a   Buscail, Jérome ^a   Soulillou, Jean Paul ^a   Anegon, Ignacio ^a  

^a INSERUM U437   (France)

Author keywords

CD59; CMV promoter; complement; transgenic rats; transplantation

Indexed keywords

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0030297845     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01980209     Document Type: Article

References (31)

1. Azimzadeh, A., Wolf, P., Fabre, M., Odeh, M., Charreau, B., Beller, J. P., Soulillou, J. P. and Anegon, I. (1996) Rat-to-primate heart xenograft hyperacute rejection: model assessment, immunological and histological analysis. Transplantation in press.
2. Baldwin, W. M., Pruitt, S. K., Brauer, R. B., Daha, M. R. and Sanfilippo, F. (1995) Complement in organ transplantation: contributions to inflammation, injury, and rejection. Transplantation 59, 797-808.
3. Brauer, R. B., Baldwin, W. M., Ibrahim, S. and Sanfilippo, F. (1995) The contribution of terminal complement components to acute and hypercute allograft rejection in the rat. Transplantation 59, 288-93.
4. Charreau, B., Cassard, A., Tesson, L., Le Mauff, B., Navenot, J. M., Blanchard, D., Lublin, D., Soulillou, J. P. and Anegon, I. (1994) Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 58, 1222-9.
5. Charreau, B., Tesson, L., Pourcel, C., Soulillou, J. P. and Anegon, I. (1996) Transgenesis in rat; technical aspects and models. Transgenic Res. 5, 223-234.
6. Chomczynsky, P. and Sacchi, N. (1987) Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 62, 156-9.
7. Fodor, W. L., Williams, B. L., Matis, L. A., Madri, J. A., Rollins, S. A., Knight, J. W., Velander, W. and Squinto, S. P. (1994) Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl Acad. Sci. USA 91, 11153-7.
8. Furth, P. A., Hennighausen, L., Baker, C., Beatty, B. and Woychick, R. (1991) The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucl. Acid Res. 19, 6205-8.
9. Furth, P. A., St. Onge, L., Böger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H. and Hennighausen, L. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl Acad. Sci. USA 91, 9302-6.
10. Gill, T., Smith, G. J., Wissler, R. W. and Kunz, H. W. (1989) The rat as an experimental animal. Science 245, 269-76.
11. Ivell, R. (1992). "All that glisters is not gold"-common testis gene transcripts are not always what they seem. Internat. J. Andrology 15, 85-92.
12. Kagiyama, A., Savage, H. E., Michael, L. H., Hanson, G., Entman, M. L. and Rossen, R. D. (1989) Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochrondrial origin that bind human C1q and fix complement. Circ. Res. 64, 607.
13. Kennedy, S. P., Rollins, S. A., Burton, W. V., Sims, P. J., Bothwell, A. L., Squinto, S. P. and Zavoico, G. B. (1994) Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Transplantation 57, 1494-501.
14. Korty, P. E., Brando, C. and Shevach, E. M. (1991) CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol. 146, 4092-8.
15. Kovacsovics, T. J., Peitsch, M. C., Kres, A. and Isliker, H. (1987) Antibody-independent activation of C1: I. Differences in the mechanism of C1 activation by non-immune activators and by immune complexes: Cr1-independent activation of C1s by cardiolipin vesicles. J. Immunol. 138, 1864-70.
16. Leventhal, J. R., Dalmasso, A. P., Cromwell, J. W., Platt, J. L., Manivel, C. J., Bolman, R. M. and Matas, A. J. (1993) Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857-66.
17. Mercer, E. H., Hoyle, G. W., Kapur, R. P., Brinster, R. L. and Palmiter, R. D. (1991) The dopamine β-hydroxylase gene promoter directs expression of the E. coli lacZ to sympathic and other neurons in adult transgenic mice. Neuron 7, 703-16.
18. Meri, S., Waldmann, H. and Lachmann, P. J. (1991) Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab. Invest. 65, 532-37.
19. Morgan, B. P. (1989) Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. 264, 1-14.
20. Morgan, B. P. and Men, S. (1994) Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15, 369-96.
21. Pinkert, C. A. (1994) Transgenic pig models for xenotransplantation. Xeno 2, 10-5.
22. Reuter, G. and Spierer, P. (1992) Position effect variegation and chromatin proteins. BioEssays 14, 605-12.
23. Rollins, S. A. and Sims, P. J. (1990) The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 144, 3478-83.
24. Rollins, S. A., Zhao, J., Ninomiya, H. and Sims, P. J. (1991) Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 146, 2345-51.
25. Schmidt, E. V., Christoph, G., Zeller, R. and Leder, P. (1990) The cytomegalovirus enhancer: a pan-active control clement in transgenic mice. Mol. Cell. Biology 10, 4406-11.
26. Sims, P. J., Rollins, S. A. and Wiedmer, T. (1989) Regulatory control of complement on blood platelets. J. Biol. Chem. 264, 19228-35.
27. Sommerville, C. A., Kyriasis, A. G., McKenzie, A., Allison, J., Pearse, M. J. and D'Apice, A. J. (1994) Functional expression of human CD59 in transgenic mice. Transplantation 58, 1430-5.
28. Väkedä, A., Laurila, P. and Meri, S. (1992) Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab. Invest. 67, 608-16.
29. Van Den Berg, C. W. and Morgan. B. P. (1994) Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J. Immunol. 152, 4095-9.
30. Waldman, W. J., Adams, P. W., Orosz, C. G. and Sedmark, D. D. (1992) T lymphocytes activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 55, 887-96.
31. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concido, M. F., Boyle, M. D., Roux, K. H., Weisfeldt, M. L. and Fearon, D. T. (1990) Soluble complement receptor type 1 : in vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis. Science 249, 146-55.